Globus Medical (GMED) Tops Q4 EPS by 10c; offers guidance

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.84, $0.10 better than the analyst estimate of $0.74. Revenue for the quarter came in at $657.29 million versus the consensus estimate of $635.43 million.

GUIDANCE:

Globus Medical sees FY2025 EPS of $3.10-$3.40, versus the consensus of $3.43. Globus Medical sees FY2025 revenue of $2.8-2.9 billion, versus the consensus of $2.672 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Iambic Therapeutics (IAM) files for proposed IPO
• Alibaba (BABA) Targets 20gw Of Data Center Capacity By 2032 - Bloomberg